Proteomic analysis of sensitive and multi drug resistant Mycobacterium tuberculosis strains


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Multidrug-resistant tuberculosis (MDR-TB) is caused by bacteria that are resistant to the most effective anti TB drugs (Isoniazid and Rifampicin) with or without resistance to other drugs. Novel intervention strategies to eliminate this disease based on finding proteins can be used for designing new drugs or new and reliable kits for diagnosis. The aim of this study was to compare the protein profile of MDR-TB with sensitive isolates. Two-dimensional gel electrophoresis (2DE) along with mass spectrometry is a powerful and effective tool to identification and characterization of Mycobacterium tuberculosis. Two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry was used for diagnosis and comparison of proteins. We identified 14 protein spots in MDR-TB isolates that 2DE analysis showed these spots absent in M. tuberculosis sensitive isolates (Rv1876, Rv0379, Rv0147, Rv2031c, Rv3597c, Rv1886c, MT0493, Rv0440, Rv3614c, Rv1626, Rv0443, Rv0475, Rv3057 and unknown protein. The results showed 22 protein spots which were up regulated (or expressed) by the MDR-TB isolates, (Rv1240, Rv3028c, Rv2971, Rv2114c, Rv3311, Rv3699, Rv1023, Rv1308, Rv3774, Rv0831c, Rv2890c, Rv1392, Rv0719, Rv0054, Rv3418c, Rv0462, Rv2215, Rv2986c, Rv3248c and Rv1908c)). Two up regulated protein spots were identified in sensitive isolate (Rv1133c and Rv0685). These data will provide valuable clues in further investigation for suitable TB rapid tests or drug targets against drug resistant and sensitive of M. tuberculosis.

About the authors

Shamsi Yari

Tuberculosis Department

Email: tbchemistry@gmail.com
Iran, Islamic Republic of, Tehran

Alireza Hadizadeh Tasbiti

Tuberculosis Department

Email: tbchemistry@gmail.com
Iran, Islamic Republic of, Tehran

Mostafa Ghanei

Tuberculosis Department; Chemical Injury Research Center

Email: tbchemistry@gmail.com
Iran, Islamic Republic of, Tehran; Tehran

Mohammad Ali Shokrgozar

National Cell Bank of Iran

Email: tbchemistry@gmail.com
Iran, Islamic Republic of, Tehran

Behrouz Vaziri

Protein Chemistry Unit, Biotechnology Research Center

Email: tbchemistry@gmail.com
Iran, Islamic Republic of, Tehran

Reza Mahdian

Molecular Medicine Dept, Biotechnology Research Center

Email: tbchemistry@gmail.com
Iran, Islamic Republic of, Tehran

Fatemeh Yari

Blood Transfusion Research Center

Email: tbchemistry@gmail.com
Iran, Islamic Republic of, Tehran

Ahmadreza Bahrmand

Tuberculosis Department

Author for correspondence.
Email: tbchemistry@gmail.com
Iran, Islamic Republic of, Tehran

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Pleiades Publishing, Ltd.